OUR APPROACH
Our Discovery Engine
A proprietary in-house discovery platform enables us to see the real-world interaction between drug and target in rapid, sequential, structural SNÅPshots. With each SNÅP, we bring speed, clarity, and focus to structure-based drug design.
Driven by clear patient needs
Using our SNÅP Discovery Engine, we drive towards innovative molecular structures that are designed to specifically address key drivers of a patient’s disease. Our next-generation candidates are designed to provide deeper responses, and in cancer, to overcome mechanisms of resistance to currently available treatments.
Quick and routine data generation
Full structural SNÅPshots for our discovery compounds are obtained in as little as 7 days, rather than weeks to months. This enables us to rapidly iterate on designs week after week with a clear line of sight into how each modification moves us closer to our goal.
full structural SNÅPshots in as little as 7 days
Focused generation of empirical (real-world) data
Our engine prioritizes a select number of critical assays, with an emphasis on datasets that can drive precise design refinements. Together, these data form a full picture or structural “SNÅPshot” for each discovery compound that reveals clear opportunities to refine its molecular design, down to a tenth of an angstrom (Å).
Experience translated into innovation
We have distilled decades of experience into process optimizations and innovations. Our advancements to the art of protein crystallography are key to reducing the time-to-structure from multiple weeks to days:
Purpose-built pipeline
Leveraging insights from rapid, sequential SNÅPshots, we move with angstrom-level precision towards developing selective inhibitors designed to deliver deeper, more durable responses for people.